Pierre-Henri Gabriel

Angel investor in Winterthur

Invests in AI

Pierre-Henri Gabriel's investor profile lists AI alongside Healthcare & Biotech, Digital Health & HealthTech and SaaS & Enterprise, at early-stage venture. The record holds 1 deal, among them Mirelo AI.

Email Investor

Email Investor

Credits to line up before an early-stage round

Pierre-Henri Gabriel backs companies at early-stage venture. A few of the larger credit programs on AI Perks for teams at that point:

Portfolio on record

Portfolio companies

  • Mirelo AI

Investment focus

Backs startups in
Artificial Intelligence, Healthcare & Biotech, Digital Health & HealthTech, SaaS & Enterprise, Consumer & Retail, E-commerce & D2C and 11 more
Rounds
Early-stage venture
Profile
Angel investor
Deals on record
1
Based in
Winterthur, Switzerland

Ready to pitch AI investors?

AI Perks profiles show public professional information only, so there are no contact details here. Continue to find investors, send your pitch and track the replies.

Email Investor

Email Investor

More AI investors on AI Perks

Browse all AI investors

Questions founders ask

Does Pierre-Henri Gabriel invest in AI startups?
Yes. Artificial Intelligence is one of the sectors on Pierre-Henri Gabriel's investor profile, together with Healthcare & Biotech, Digital Health & HealthTech and SaaS & Enterprise. The stages on record are early-stage venture.
Which companies has Pierre-Henri Gabriel backed?
The record lists 1 deal, including Mirelo AI. None of them has a perk listed on AI Perks yet.
What credits can a startup claim before pitching Pierre-Henri Gabriel?
For a company raising an early-stage round, AI Perks lists credits such as Appwrite (up to $20,000), NVIDIA (up to Varies), Redis (up to $10,000) and Vertex AI (up to $350,000), with each program's terms and how to apply.
Does AI Perks publish investor contact details?
No. AI Perks profiles show public professional information only: name, role, location, stages, sectors and the portfolio on record. To reach investors, continue with the Email Investor button below.Email Investor

Email Investor

Source: public professional information. Is this you? Request removal

Email Investor

Email Investor